Sector
PharmaceuticalsOpen
₹334Prev. Close
₹338.6Turnover(Lac.)
₹3.22Day's High
₹344.9Day's Low
₹33052 Week's High
₹64652 Week's Low
₹302.05Book Value
₹224.66Face Value
₹10Mkt Cap (₹ Cr.)
103.5P/E
11.74EPS
28.83Divi. Yield
0.330 May 2024
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 19 Sep, 2024
30 May 2024
12:00 AM
AGM
Announcement Date: 30 May, 2024
30 May 2024
12:00 AM
BookCloser
31 Dec 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 61.91 | 60.05 | 43.73 | 26.55 |
Net Worth | 65 | 63.14 | 46.82 | 29.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 179.01 | 137.45 | 111.13 | 92.52 |
yoy growth (%) | 30.23 | 23.67 | 20.12 | 30.19 |
Raw materials | -164.24 | -125.61 | -102.62 | -81.92 |
As % of sales | 91.74 | 91.38 | 92.33 | 88.54 |
Employee costs | -1.49 | -1.44 | -1.38 | -1.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 7.36 | 5.79 | 2.15 | 4.92 |
Depreciation | -0.49 | -0.42 | -0.41 | -0.41 |
Tax paid | -2.01 | -1.54 | -0.62 | -1.7 |
Working capital | 3.61 | 5.53 | -1.22 | 5.89 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 30.23 | 23.67 | 20.12 | 30.19 |
Op profit growth | 30.75 | 108.66 | -46.6 | 61.6 |
EBIT growth | 27.49 | 110.67 | -44.39 | 69.61 |
Net profit growth | 25.87 | 175.9 | -52.26 | 83.35 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Lalit Mehta
Director & CFO
Rajesh Mehta
Independent Director
Renu P Dharod
Executive Director
Megh Mehta
Company Sec. & Compli. Officer
Nishant Kankaria
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Samrat Pharmachem Ltd
Summary
Samrat Pharmachem Limited was incorporated on June 16, 1992. The Companys principal activities are manufacturing and selling chemicals.The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.
Read More
What is the Samrat Pharmachem Ltd share price today?
The Samrat Pharmachem Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹335 today.
What is the Market Cap of Samrat Pharmachem Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Samrat Pharmachem Ltd is ₹103.50 Cr. as of 09 May ‘25
What is the PE and PB ratio of Samrat Pharmachem Ltd?
The PE and PB ratios of Samrat Pharmachem Ltd is 11.74 and 1.51 as of 09 May ‘25
What is the 52 Week High and Low of Samrat Pharmachem Ltd?
The 52-week high/low is the highest and lowest price at which a Samrat Pharmachem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Samrat Pharmachem Ltd is ₹302.05 and ₹646 as of 09 May ‘25
What is the CAGR of Samrat Pharmachem Ltd?
Samrat Pharmachem Ltd's CAGR for 5 Years at 36.24%, 3 Years at -6.64%, 1 Year at -10.53%, 6 Month at -31.86%, 3 Month at -1.80% and 1 Month at 5.94%.
What is the shareholding pattern of Samrat Pharmachem Ltd?
The shareholding pattern of Samrat Pharmachem Ltd is as follows:
Promoters - 49.09 %
Institutions - 3.24 %
Public - 47.67 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
